Table 1.
Treatment of upper respiratory infection
Treatment | Benefit | Data | Level of evidence [reference] |
---|---|---|---|
Antibiotics | Not likely beneficial | Aa[9] | |
Decongestants | May be beneficial | Compared with placebo, a single dose of an oral or topical decongestant produced a significant 13% reduction in subjective symptoms | Aa[27] |
There was no benefit from repeated use over several days | |||
There are limited data to support its use in children | |||
Antihistamine | May be beneficial | Reduced the symptoms of runny nose and sneezing for the first 2 d of colds | Aa[10] |
Vitamin C | Unknown effectiveness | 1 g daily or more produces about 15% fewer symptomatic days per episode | Bb[11] |
Zinc | Unknown effectiveness | May reduce duration of cold symptoms at 7 d compared with placebo | Bb[12] |
Two randomized controlled trials found that zinc intranasal gel reduced the mean duration of cold symptoms compared with placebo | |||
Echinacea | Unknown effectiveness | Some preparations of Echinacea may be better than placebo for cold treatment | Bb[13] |
Steam | Unknown effectiveness | Conflicting evidence of the efficacy of steam inhalation at 40°–47°C in the reduction of cold symptoms | Bb[14] |
Level A is consistent, good-quality patient-oriented evidence (SORT evidence rating system).
Level B is inconsistent or limited-quality patient-oriented evidence (SORT evidence rating system).